Tasman Resources Ltd Overview
Tasman Resources is a Perth-based, Solomon-family-controlled junior explorer whose value rests on three assets: a 49% free-carried interest in the Lake Torrens iron oxide copper-gold (IOCG) project (EL 6416), located roughly 30 km north of BHP's Olympic Dam mine, where Fortescue is sole-funding exploration to earn up to 80%; the 100%-owned Parkinson Dam polymetallic project (EL 6495) on the southern Gawler Craton, which hosts a historic high-grade intercept of 21 m at 21 g/t gold and 83 g/t silver; and a 12.57% listed stake in Eden Innovations (EdenCrete concrete admixtures and OptiBlend dual-fuel systems), marked at about A$12.3 million at 30 June 2026. Following the September 2025 deconsolidation of Eden and two placements totalling about A$6 million, Tasman is debt-free with about A$5.7 million cash, and has entered its most active drilling window in over a decade, with maiden Titan West and expanded 20-hole Parkinson Dam campaigns imminent.
What the company does
Tasman Resources is a mineral exploration company. It does not produce, mine, process or sell minerals, and it has no mineral resources or ore reserves defined under the JORC Code on any project. Its business consists of acquiring, holding and exploring tenements in South Australia, and of holding (and occasionally realising) strategic equity investments.
The company's own description in its FY2026 Annual Report states that its primary focus during the year was mineral exploration for a range of commodities within its South Australian tenements, namely the Lake Torrens IOCG base-metal project and the Parkinson Dam gold, silver, lead and zinc project. The FY2026 report also explicitly states that the Group is a mineral exploration company that does not generate operating revenue (FY2026 AR, Directors' Report and Note 1).
The Annual Report describes Tasman's investment portfolio as comprising: (i) a 49% joint venture interest with FMG Resources Pty Ltd in the Lake Torrens Project; (ii) a 100% interest in the Parkinson Dam Project; and (iii) its shareholding in Eden Innovations Ltd. The board characterises all of its long-term investments as start-up ventures in different market sectors, considered to have significant upside but carrying the risks of "greenfield" investments (FY2026 AR, Investment Strategies).
Business model and revenue model
| Revenue model element | Pre-8 Sep 2025 (consolidated Eden era) | Post-8 Sep 2025 (current) |
|---|---|---|
| Product sales | EdenCrete concrete admixture sales (USA) and OptiBlend dual-fuel kit sales (USA, India), consolidated from Eden | — |
| Services | OptiBlend installation and servicing (consolidated from Eden) | — |
| Subscription / licensing | — | — |
| Investment income | Interest; occasional sale of listed securities (e.g. Conico shares) | Interest; realisation of Eden securities (e.g. A$600,000 Eden option sale, 2026); equity-accounted share of Eden profit or loss |
| Exploration value creation | Free-carry on Lake Torrens via Fortescue; self-funded work at Parkinson Dam | Same, with Parkinson Dam now funded by FY2026 placements |
| Funding model | Related-party loans from Arkenstone Pty Ltd and March Bells Pty Ltd ("ArkBells"), rights issues, Eden capital raisings | Equity placements, sale of non-core Eden securities; no debt at 30 June 2026 |
The independent characterisation is that Tasman is a "prospect generator plus listed-investment holding company". Its economic model is to: (a) generate drill targets cheaply through geophysics and reinterpretation of historic data; (b) farm out capital-intensive deep targets to major-company partners (historically Rio Tinto Exploration, currently Fortescue) in exchange for a free-carried minority interest; (c) self-fund shallower, cheaper targets (Parkinson Dam) to retain 100% exposure; and (d) use its Eden stake as a liquid treasury reserve that can be monetised to fund drilling.
Value chain position
Tasman sits at the very front of the mining value chain: greenfield and brownfield exploration. Any discovery would require resource definition drilling, studies, permitting and development financing well beyond Tasman's current capacity. On Lake Torrens, Fortescue as joint venture manager controls operations, budgets and drilling. Tasman's influence over that asset is therefore as a minority non-operating partner.
Customer types and end markets
Tasman has no customers in the conventional sense. The ultimate "buyers" of its output would be: (a) larger mining companies seeking to acquire discoveries or farm into projects (e.g. Fortescue, BHP and other Gawler Craton operators); and (b) equity investors who price exploration optionality. The commodities targeted are copper and gold (Lake Torrens, Parkinson Dam IOCG and porphyry targets), and gold, silver, lead and zinc (Parkinson Dam epithermal targets).
Through its Eden stake, Tasman retains indirect exposure to: the US and Indian ready-mix concrete and infrastructure markets (EdenCrete, including Holcim/Amrize group plants in Colorado and Ecuador); and the distributed power generation, oilfield and back-up power markets (OptiBlend) (FY2025 AR, Forecast Increased Revenue).
Strategy
Stated strategy (themes from FY2026 Annual Report and 2026 announcements)
The company's stated strategy, synthesised from its own disclosures, has five themes:
-
Drill-test the portfolio in 2026-2027. The Chairman described 2026 as potentially transformative, with the focus turning to execution of the expanded Parkinson Dam programme and Fortescue's Titan West drilling (ASX 25 May 2026). The July 2026 announcement described the upcoming programmes as heralding a very interesting six to twelve months (ASX 27 July 2026).
-
Partner-funded exposure to deep, expensive IOCG targets. Lake Torrens is free-carried by Fortescue under the FJVA, giving shareholders exposure without proportional capital risk (ASX 25 May 2026, as reported).
-
Retain 100% of shallower, self-fundable targets. Parkinson Dam is fully owned and funded from the FY2026 placements and Eden option proceeds (FY2026 AR).
-
Use the Eden stake as a strategic treasury reserve. Retain Eden shares for now; sell non-core Eden securities (options sold June 2026); potentially sell shares if drilling funds are required; consider ways to return Eden value to Tasman shareholders (FY2026 AR).
-
Grow the project pipeline. The March 2026 quarterly noted Tasman is actively reviewing new exploration acquisition opportunities (InvestSMART summary of April 2026 quarterly).
Strategic initiatives in the last 24 months
| Initiative | Date | Description | Target / status | Source |
|---|---|---|---|---|
| Balance sheet restructure and Eden separation | Mar 2025 to Sep 2025 | ArkBells refinance Eden's debt to Noble; Tasman repays ArkBells; Eden's dilution triggers deconsolidation | Completed; Tasman debt-free at 30 June 2026 | FY2025 AR; FY2026 AR |
| Parkinson Dam target generation | Apr 2024 to 2026 | IP, gravity, two Archimedes ACM reviews, 2026 comprehensive review (60 targets) | Completed; 20 targets selected | FY2025 AR; FY2026 AR |
| Parkinson Dam drilling programme | 2026 to 2027 | Up to 20 RC holes, depth to about 600 m, testing epithermal, IOCG and porphyry targets | Fully approved (PEPR ~14 Oct 2026); commencement guided December 2026 or early 2027 | FY2026 AR; Discovery Alert 14 Oct 2026 |
| Titan West drilling (Fortescue) | 2,026 | Two holes, RC pre-collars with diamond tails, testing coincident gravity, magnetic and MT anomalies | Heritage complete; PEPR pending at 30 Sep 2026; rig now expected late Oct or Nov 2026 | FY2026 AR |
| Capital raisings | Oct 2025; May 2026 | A$2.0 million placement (Peak lead manager, 1-for-2 free options) and A$4.05 million placement at A$0.041 (no fees) | Completed | FY2026 AR |
| Eden option monetisation | June 2026 | Sale of EDEO and EDEOD options for A$600,000 | Completed | FY2026 AR |
| Board renewal | Nov 2025; May 2026 | Two new NEDs replacing two long-serving directors | Completed | FY2026 AR |
| Settlement of related-party liabilities | Dec 2025 | Shareholder loans and accrued director fees converted to shares at A$0.0125 | Completed | FY2026 AR Note 18 |
Cost programmes, ESG commitments and guidance
No formal cost-reduction programme with numerical targets has been announced for Tasman stand-alone (Eden had previously targeted savings of up to about US$864,000 per year from US property sales; FY2025 AR). No sustainability or ESG targets have been announced. Management has not issued financial guidance or medium-term financial targets. Its only quantitative forward-looking statement is that the directors' 12-month cash flow forecast indicates sufficient funds to complete planned exploration, including the Parkinson Dam drilling programme, and to meet corporate and administrative commitments (FY2026 AR).
Products & Services
Tasman does not sell products. Its "portfolio" consists of exploration projects and an equity investment. Each is catalogued below. Eden's product lines are included because Eden was consolidated until September 2025 and remains Tasman's largest single asset by market value.
Exploration Project: Lake Torrens IOCG Project (EL 6416)
| Attribute | Detail | Source |
|---|---|---|
| Tenement | Exploration Licence 6416, South Australia | FY2026 AR |
| Area | Approx. 1,079 km² | Tasman investor presentation (2024); Pearler |
| Location | About 30 km north of BHP's Olympic Dam copper-uranium-gold-silver mine, eastern Gawler Craton / Stuart Shelf | FY2026 AR |
| Ownership | Tasman 49%; FMG Resources Pty Ltd (wholly owned Fortescue subsidiary) 51% and JV manager | FY2026 AR |
| Farm-in terms | Fortescue earned 51%; can move to 80% by sole-funding a total of A$11 million. Reported spend approx. A$7.3 million to end of March 2026. The board describes the remaining obligation as a further A$7 million of sole funding beyond the 51% stage. Tasman may reduce to 20% if Fortescue completes. | FY2026 AR; ASX 27 July 2026 |
| Target style | Iron oxide copper-gold (IOCG), Olympic Dam analogue | FY2026 AR |
| Prospects | Vulcan (incl. Vulcan South, Vulcan North, Vulcan West), Titan (Titan East), Titan West, Bill's Lookout | FY2026 AR; FY2025 AR |
| Key historic results | Vulcan discovered by Tasman (first hole late 2009); best reported Vulcan South deep intercept 21 m at 1.69% Cu below 1,310 m downhole | SARIG; Mining Technology |
| FY2026 work | Fortescue completed a large MT survey across Titan West and Bill's Lookout, identifying a conductor extending about 1,000 m into basement or a 30 to 50 ohm-m body extending to 2 to 3 km depth, coincident with a dense gravity body. Geochronology samples submitted to University of Adelaide; SCIP, magnetic susceptibility, density and pXRF data collected. | FY2026 AR |
| Next step | Two-hole programme at Titan West: RC pre-collars followed by diamond tails. Drilling contractor DDH1 Drilling (per April 2026 quarterly). Timing slipped from June/July to late August, and is now planned for late October or November 2026. Titan West PEPR lodged 6 May 2026; pending approval at reporting date. | FY2026 AR; ASX quarterly April 2026 |
| Historical context | The only historic hole at Titan West (BD2) was drilled by Western Mining Corporation in 1981; Tasman states it did not adequately test the gravity target due to hole location | ASX 27 July 2026; ASX 12 Mar 2026 |
| Native title / heritage | Kokatha Aboriginal Corporation (survey completed 21 Apr 2026); Arabana Aboriginal Corporation (survey completed 9 June 2026) | FY2026 AR |
| Tasman commitments | Tenement rentals and minimum expenditure expected to be met by Fortescue | FY2026 AR Note 17 |
| Carrying value | Part of the A$4,308,317 capitalised exploration and evaluation asset (split by project not disclosed) | FY2026 AR Note 7 |
Exploration Project: Parkinson Dam Project (EL 6495)
| Attribute | Detail | Source |
|---|---|---|
| Tenement | Exploration Licence 6495, South Australia | FY2025 AR |
| Area | Approx. 41 km² | Tasman investor presentation (2024) |
| Location | Southern margin of the Gawler Craton, which hosts Olympic Dam, Prominent Hill, Carrapateena and Oak Dam | FY2025 AR |
| Ownership | 100% Tasman | FY2026 AR |
| Target styles | Epithermal gold-silver (lead-zinc), IOCG and porphyry copper-gold | FY2026 AR |
| Host geology | Mineralisation mostly hosted by the Mesoproterozoic Corunna Conglomerate; quartz veining with sericite, chlorite and sulphide alteration over about 4.5 km² | Tasman website |
| Key historic results | PD63: 21 m at 21 g/t Au and 83 g/t Ag incl. 9 m at 31 g/t Au and 152 g/t Ag (June 2007). PD70: 50 m at 0.9% Zn and 0.3% Pb. Early follow-up diamond hole: 1.66 m at 7.6% Pb, 10.5% Zn, 0.4% Cu, 1.2 g/t Au, 120 g/t Ag. | FY2026 AR; 2024 investor presentation; Tasman website |
| Historic drilling | About 80 to 81 holes, 2006 to 2009 | FY2026 AR; TipRanks Oct 2026 |
| 2024 to 2026 work | IP survey (Apr 2024), Archimedes ACM review (June 2024), infill gravity survey on 200 m grid (Sep 2024), second ACM review (Dec 2024; six targets), comprehensive 2026 review by Archimedes Consulting and consulting geologist Tony Belperio identifying 60 targets, from which up to 20 priority targets were selected. A circular gravity anomaly of about 500 m radius was identified beneath PD63 at about 1,100 m depth, interpreted as a potential intrusive body or feeder. | FY2025 AR; FY2026 AR |
| Next step | Up to 20 reverse circulation (RC) holes to depths of up to about 600 m; all targets untested. Heritage survey (Barngarla) completed 1 July 2026; PEPR approval received about 14 Oct 2026. Annual report guided commencement in December 2026 or early 2027, subject to rig availability. | FY2026 AR; Discovery Alert 14 Oct 2026 |
| Funding | A$4.025 million placement plus A$600,000 from Eden option sale allocated to the programme | FY2026 AR |
| Minimum commitments | Tenement rental A$1,000 and exploration expenditure A$40,000 for the next 12 months | FY2026 AR Note 17 |
Equity Investment: Eden Innovations Ltd (ASX: EDE)
| Attribute | Detail | Source |
|---|---|---|
| Holding at 30 June 2026 | 76,821,206 shares = 12.57% of 611,130,202 Eden shares on issue | FY2026 AR Note 8 |
| Market value at 30 June 2026 | A$12,291,393 (A$0.16 per share, Level 1) | FY2026 AR Note 8 |
| Carrying value at 30 June 2026 | A$1,751,581 (equity method) | FY2026 AR Note 8 |
| Ownership trajectory | 28.27% (30 June 2023), 33.9% (Dec 2024), 32.0% (30 June 2025), 18.87% (8 Sep 2025), 13.95% (31 Dec 2025), 12.57% (30 June 2026) | Tasman ARs FY2023, FY2025, FY2026; HY Dec 2024 |
| Options | All EDEO and EDEOD options sold June 2026 for A$600,000 (3,571,428 EDEO; 13,661,403 EDEOD) | FY2026 AR |
| Stated intent | Retain all Eden shares for the time being; may sell some or all if funds are needed, particularly for drilling; continuing to consider options to return value from Eden to Tasman shareholders (an in-specie distribution was flagged as a possibility in the FY2025 AR) | FY2026 AR; FY2025 AR |
| Significant influence judgement | Below 20%, but equity method retained due to a common director, being one of Eden's largest shareholders, and material transactions between the companies | FY2026 AR Note 1(w) |
| Attribute | Detail | Source |
|---|---|---|
| Description | Carbon-based concrete admixture range designed to enhance concrete strength, abrasion resistance and durability | FY2025 AR |
| Variants | EdenCrete® (original), EdenCrete® Pz and Pz7 (pozzolanic variants enabling higher fly-ash substitution for Portland cement) | FY2025 AR |
| Launch | First sold in the USA in 2016 | FY2026 AR |
| Markets | USA, India, France, Australia; Ecuador and Canada via Holcim group plants | FY2025 and FY2026 ARs |
| Approvals | Approved by Departments of Transportation in 21 US states; Georgia DOT has specified EdenCrete in full-depth concrete slab replacements since 2017 | FY2026 AR |
| Commercial traction | Orders to Holcim (from July 2024) with dispensing equipment; seven Colorado plants with dispensing equipment (up five in 2025); nine Ecuador plants (up two); first Canadian order (US$16,000) from Holcim subsidiary Innocon, Toronto (Aug 2025); EdenCrete sales up 114% in 2025 vs 2024; Pz7 production capacity increased 500% via process revision | FY2025 AR |
| FY2025 sales | A$1,351,582 (USA) | FY2025 AR Note 2A |
| Attribute | Detail | Source |
|---|---|---|
| Description | Retrofit kits enabling diesel generator sets to run on a blend of diesel and natural gas | FY2025 AR |
| History | Many hundreds sold since 2009, mainly in the USA and India | FY2025 AR |
| Market drivers | Shale oil and gas drilling/fracking prime power; back-up power for hospitals, prisons, military bases, data centres, shopping malls; fuel cost and carbon reduction | FY2025 AR |
| FY2025 sales | A$1,025,178 (USA) and A$56,280 (India) | FY2025 AR Note 2A |
| India | Eden India historically profitable, paid dividends to its parent in FY2023 and FY2024; record OptiBlend India sales of about A$2.69 million in FY2023 | FY2025 AR; Eden FY2023 AR |
Eden product line A — EdenCrete® concrete admixtures
Eden product line B — OptiBlend® dual-fuel systems
Pricing models: Not publicly disclosed for any Eden product.
Former and minor investments
| Investment | Status | Source |
|---|---|---|
| Conico Ltd (ASX: CNJ) | 132,403,387 shares sold during FY2025; Noble retains 1,655,043 CNJO options (post-consolidation, A$0.26 strike, expiring 31 Dec 2026) | FY2025 AR |
| Pernatty IOCG project | Listed by some aggregators as a historic project; not listed among current tenements in FY2025 or FY2026 annual reports (only EL 6416 and EL 6495) | Simply Wall St (aggregator); FY2025 AR Table 1 |
Financial Narrative
Important interpretive note: FY2022 to FY2025 figures consolidate Eden Innovations (a loss-making operating business with debt and property). FY2026 includes only about ten weeks of Eden consolidation and a one-off, non-cash A$19.5 million gain on loss of control. No year in this series reflects a "steady-state" Tasman. Underlying figures are derived where possible.
Income statement (A$)
Sources: FY2026 AR (FY2026, FY2025 comparatives); FY2025 AR (FY2024 comparatives); FY2025 AR remuneration report five-year table (attributable losses and consolidated comprehensive losses for FY2022 and FY2023); Eden/Tasman FY2023 AR (FY2022 and FY2023 revenue).
Margins (%)
Derived. FY2026 operating, EBITDA and net margins are not meaningful because the result is driven by a non-cash gain on a revenue base of only A$0.19 million.
Revenue CAGR: FY2022 to FY2025 (3-year, consolidated Eden era): -16.3% per annum (derived). FY2022 to FY2026 (4-year, distorted by deconsolidation): -53.8% per annum (derived). Neither is meaningful for valuing the current exploration company.
Balance sheet (A$, 30 June)
Sources: FY2026 AR; FY2025 AR; FY2025 AR statement of changes in equity (30 June 2023 equity); FY2025 AR cash flow statement (30 June 2023 cash as opening balance).
Debt composition at 30 June 2025 (A$): Arkenstone/March Bells related-party loan 8,159,857 (unsecured, 9.97%, at call); iBorrow REIT LP loan 8,829,358 (secured over three Eden US properties, 9.75%, USD, due January 2026); US SBA loan 41,113 (1%). At 30 June 2026, the ArkBells loans had been repaid or converted (A$8.19 million repaid; A$44,000 converted to shares) and the iBorrow and SBA loans left the group on Eden's deconsolidation (A$8.80 million) (FY2026 AR Note 11).
Off-balance-sheet value: The Eden stake is carried at A$1.75 million but had a market value of A$12.29 million at 30 June 2026. Adjusting book equity for this gap gives an adjusted net asset value of about A$22.1 million (derived: 11,563,292 - 1,751,581 + 12,291,393), equivalent to about A$0.040 per share on 553.99m shares.
Cash flow (A$)
Sources: FY2026 AR; FY2025 AR.
Quarterly cash run-rate (Appendix 5B): Operating outflows of A$109,000 (March 2026 quarter) and A$247,000 (June 2026 quarter); cash of A$1.461 million at 31 December 2025 (Appendix 5B summaries via InvestSMART). The June 2026 quarter included A$579,000 net investing inflow and the A$4 million placement.
Ratios
All derived from primary statements. ROIC and net debt/EBITDA are not meaningful (negative EBITDA in FY2024 and FY2025; net cash and gain-driven EBITDA in FY2026). The cash conversion cycle is not meaningful for an explorer and was not disclosed for the Eden era. FY2026 ROE, ROA and interest coverage are inflated by the non-cash deconsolidation gain and should not be read as operating performance.
Commentary on trends, inflections and drivers
FY2022 to FY2023: Eden growth, rising leverage. Consolidated revenue rose from A$4.15 million to A$4.70 million on record OptiBlend sales in India, while EdenCrete sales fell 20% (Eden FY2023 AR). However, Eden's cost base, its US property portfolio and refinancing to the iBorrow REIT facility drove continuing losses, and Tasman reported a consolidated total comprehensive loss of A$20.4 million in FY2023 (FY2025 AR five-year table).
FY2024: the trough. Revenue more than halved to A$2.02 million as Indian OptiBlend sales collapsed (A$0.42 million vs about A$2.69 million in FY2023). A A$10.1 million impairment drove a A$18.3 million loss after tax. Equity fell from A$19.8 million to A$6.5 million. The group's working capital deficit reached A$10.7 million and the auditor's going-concern language highlighted material uncertainty (FY2025 AR).
FY2025: survival funding. Revenue recovered 21% to A$2.43 million on stronger US EdenCrete and OptiBlend sales, but the group remained reliant on Solomon-family loans (ArkBells balance A$8.16 million) and an expiring iBorrow facility. Debt peaked at A$17.0 million; debt to equity reached 7.7x. The FY2025 going-concern note made continuation contingent on the sale of Eden's Augusta, Georgia property and refinancing (FY2025 AR).
FY2026: the inflection. Three events transformed the balance sheet: (1) the loss of control of Eden on 8 September 2025 removed A$15.3 million of Eden liabilities and generated a A$19.5 million accounting gain; (2) A$8.19 million of ArkBells loans were repaid or converted (largely via Eden's repayment of the Noble loan in March 2025 and share issues); and (3) Tasman raised A$5.9 million net in new equity. The result: no borrowings, A$5.65 million cash, net current assets of A$5.5 million, and a clean going-concern opinion supported by a 12-month cash flow forecast covering the Parkinson Dam programme (FY2026 AR).
Underlying cost base. Excluding Eden, Tasman's own cash burn is modest. Quarterly operating outflows of A$109,000 to A$247,000 in 2026 imply an annualised corporate and exploration-preparation burn of roughly A$0.5 to 1.0 million before drilling. However, FY2026 employee benefits included a non-cash A$756,000 performance-rights charge, and directors' fixed fees total about A$258,000 per year.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Relationship | Function | Source |
|---|---|---|---|
Tasman Resources Ltd | Listed parent | Holds EL 6495 (Parkinson Dam, 100%) and 49% of EL 6416 (Lake Torrens JV) | FY2026 AR |
Noble Energy Pty Ltd | 100% subsidiary | Holds Tasman's Eden Innovations shares (76,821,206 at 30 June 2026); previously held Conico securities and Eden options; member of Tasman's tax consolidated group | FY2026 AR Notes 1, 8 |
Eden Innovations Ltd (ASX: EDE) | Associate (12.57% at 30 June 2026); controlled subsidiary until 8 Sep 2025 | Clean-technology company (EdenCrete, OptiBlend); subsidiaries in USA (Eden Innovations LLC) and India | FY2026 AR Note 8 |
Lake Torrens Joint Venture (EL 6416) | Unincorporated JV: Tasman 49%, FMG Resources Pty Ltd 51% (manager) | IOCG exploration (Vulcan, Titan, Titan West, Bill's Lookout) | FY2026 AR |
Revenue by Segment (AUD)
| Segment (AUD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Eden Innovations segment revenue | 4,149,161 | 4,701,130 | 2,016,640 | 2,433,040 | 188,433 |
Tasman exploration segment revenue | 0 | 0 | 0 | 0 | 0 |
Total group operating revenue | 4,149,161 | 4,701,130 | 2,016,640 | 2,433,040 | 188,433 |
Revenue by Segment (%) and Segment Margins & Growth (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Eden share of group revenue (%) | 100 | 100 | 100 | 100 | 100 |
Group operating revenue YoY growth (%) | 26.4 | 13.3 | -57.1 | 20.6 | -92.3 |
Income Statement (AUD) and Margin Analysis (%)
| Metric (AUD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating revenue | 4,149,161 | 4,701,130 | 2,016,640 | 2,433,040 | 188,433 |
Other income | — | — | 171,496 | 35,721 | 608,260 |
Gross profit (derived: revenue less raw materials, adjusted for inventory change) | — | — | 1,389,094 | 1,677,519 | 119,754 |
Employee benefits expense | — | — | 3,573,619 | 2,837,792 | 1,427,334 |
Impairment expense | — | — | 10,134,239 | 794,118 | 0 |
Finance costs | — | — | 1,426,271 | 1,861,096 | 332,519 |
Depreciation and amortisation | — | — | 1,352,509 | 857,159 | 110,326 |
Gain on loss of control of subsidiary | 0 | 0 | 0 | 0 | 19,475,094 |
Share of associate (Eden) net loss | 0 | 0 | 0 | 0 | 819,209 |
Operating income / EBIT (derived: PBT plus finance costs) | — | — | -16,839,275 | -5,846,777 | 16,834,265 |
EBITDA (derived: EBIT plus D&A) | — | — | -15,486,766 | -4,989,618 | 16,944,591 |
Underlying EBITDA (derived: excl. impairment, deconsolidation gain, associate loss) | — | — | -5,352,527 | -4,195,500 | -1,711,294 |
Profit/(loss) before tax | — | — | -18,265,546 | -7,707,873 | 16,501,746 |
Profit/(loss) after tax (total group) | — | — | -18,340,741 | -7,720,947 | 16,501,746 |
Profit/(loss) attributable to owners of Tasman | -2,842,627 | -5,718,753 | -13,132,246 | -3,016,909 | 17,510,005 |
Total comprehensive income/(loss) (group) | -6,927,524 | -20,421,762 | -14,358,157 | -7,599,403 | 18,637,753 |
EPS basic (A cents) | — | — | -1.8427 | -1.8208 | 4.4799 |
EPS diluted (A cents) | — | — | -1.8427 | -1.8208 | 3.9863 |
Dividends per share (A cents) | 0 | 0 | 0 | 0 | 0 |
Margin (%)
| Margin (%) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Gross margin | 68.9 | 68.9 | 63.6 |
Operating (EBIT) margin | -835.0 | -240.3 | — |
EBITDA margin | -767.9 | -205.1 | — |
Net margin (group) | -909.5 | -317.3 | — |
Balance Sheet (AUD)
| Metric (AUD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash and cash equivalents | — | 2,736,278 | 987,690 | 761,434 | 5,654,585 |
Total current assets | — | — | 6,253,745 | 9,585,757 | 5,671,713 |
Exploration and evaluation asset | — | — | 4,272,209 | 4,272,209 | 4,308,317 |
Intangibles (Eden IP) | — | — | 290,502 | 0 | 0 |
Property, plant and equipment | — | — | 12,548,746 | 8,235,705 | 304 |
Assets held for sale (Eden US properties) | — | — | 1,856,662 | 5,592,676 | 0 |
Investment in associate (Eden, equity method) | 0 | 0 | 0 | 0 | 1,751,581 |
Total assets | — | — | 23,497,605 | 22,093,671 | 11,731,915 |
Interest-bearing liabilities (all current) | — | — | 14,032,212 | 17,030,328 | 0 |
Long-term debt | — | — | 0 | 0 | 0 |
Total liabilities | — | — | 16,978,723 | 19,886,963 | 168,623 |
Net debt (derived) | — | — | 13,044,522 | 16,268,894 | -5,654,585 |
Total equity | — | 19,767,235 | 6,518,882 | 2,206,708 | 11,563,292 |
Equity attributable to Tasman owners | — | 16,375,103 | 3,774,306 | 3,487,082 | 11,563,292 |
Working capital (derived / reported) | — | — | -10,650,093 | -10,301,206 | 5,503,090 |
Goodwill | 0 | 0 | 0 | 0 | 0 |
Cash Flow (AUD)
| Metric (AUD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow | — | — | -5,461,430 | -3,921,627 | -1,128,963 |
Capex: exploration and evaluation | — | — | 155,517 | 0 | 36,108 |
Capex: PP&E and intangibles | — | — | 578,358 | 305,203 | 2,457 |
Total capex (derived) | — | — | 733,875 | 305,203 | 38,565 |
Free cash flow (derived: OCF less total capex) | — | — | -6,195,305 | -4,226,830 | -1,167,528 |
Proceeds from Eden option sale | 0 | 0 | 0 | 0 | 600,000 |
Cash derecognised on loss of control | 0 | 0 | 0 | 0 | 1,313,695 |
Net investing cash flow | — | — | -733,875 | -172,773 | -1,002,260 |
Equity raised by Tasman (net) | — | — | 0 | 330,056 | 5,872,264 |
Net borrowings (proceeds less repayments) | — | — | 3,396,957 | 3,278,439 | 404,842 |
Net financing cash flow | — | — | 4,453,266 | 3,866,945 | 7,045,258 |
Dividends paid | 0 | 0 | 0 | 0 | 0 |
Share buybacks | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
ROE on owners' equity (%, average equity) | -130.3 | -83.1 | 232.7 |
ROA (%, group profit / average total assets) | — | -33.9 | 97.6 |
Current ratio (x) | 0.37 | 0.48 | 33.64 |
Debt to equity (x) | 2.15 | 7.72 | 0.00 |
Interest coverage (EBIT / finance costs, x) | -11.8 | -3.1 | 50.6 |
Asset turnover (revenue / closing total assets, x) | 0.086 | 0.110 | 0.016 |
Revenue by Region (AUD)
| Product x Region (AUD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
EdenCrete USA | — | — | 1,060,545 | 1,351,582 | — |
EdenCrete India | — | — | 0 | 0 | — |
EdenCrete total | 1,600,000 | 1,279,000 | 1,060,545 | 1,351,582 | — |
OptiBlend USA | — | — | 535,730 | 1,025,178 | — |
OptiBlend India | — | 2,690,000 | 420,365 | 56,280 | — |
OptiBlend total | 2,549,000 | 3,422,000 | 956,095 | 1,081,458 | — |
Total | 4,149,000 | 4,701,000 | 2,016,640 | 2,433,040 | 188,433 |
Revenue by Region (AUD) by Region
| Region (AUD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
United States | — | 2,011,000 | 1,596,275 | 2,376,760 | — |
India | — | 2,690,000 | 420,365 | 56,280 | — |
Australia (Tasman exploration) | 0 | 0 | 0 | 0 | 0 |
Region growth (%)
| Region growth (%) | FY2024 | FY2025 |
|---|---|---|
United States YoY | -20.6 | 48.9 |
India YoY | -84.4 | -86.6 |
Per-Share Data
| Price point (AUD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Share price at 30 June (A cents, as reported) | 2.9 | 1.1 | 0.6 | 0.4 | 1.5 |
Return period
| Return period | Approx. return | Basis / source |
|---|---|---|
1 year | Strongly positive (aggregator snapshot reported +275% in early 2026) | — |
5 year | Negative (Pearler reports about -18% average annual growth over five years) | Pearler (aggregator) |
Since IPO | About -92% (Motley Fool) | Aggregator |
Valuation Snapshot
| Metric | Value | Basis |
|---|---|---|
Market capitalisation | A$16.6 million | 553,990,945 shares x A$0.030 |
Enterprise value | Approx. A$11.0 million | Market cap less A$5.65 million cash (30 June 2026); nil debt |
Look-through EV (excluding Eden stake at 30 June 2026 value) | Approx. -A$1.3 million | — |
P/E (FY2026 reported) | 0.67x | A$0.030 / A$0.0448 basic EPS; non-recurring gain, not meaningful |
P/B (reported book) | 1.44x | A$16.6 million / A$11.56 million |
P/adjusted NAV | 0.75x | A$16.6 million / A$22.1 million adjusted NAV |
EV/EBITDA | n/m | Negative underlying EBITDA |
EV/Sales | n/m | Explorer; no ongoing revenue |
Capital Markets
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividends per share (A cents) | 0 | 0 | 0 | 0 | 0 |
Buybacks (AUD) | 0 | 0 | 0 | 0 | 0 |
Securities on Issue
| Security | Number | Terms | Source |
|---|---|---|---|
Ordinary shares | 553,990,945 | — | Appendix 2A, 5 Aug 2026 |
Unlisted options | 500,000 | A$0.02, expiring 14 May 2028 | FY2026 AR |
Options (June 2025 entitlement) | 47,590,088 | A$0.05, expiring 5 June 2028 | FY2026 AR |
TASO quoted options | 119,646,000 | A$0.02, expiring 14 June 2028 (in the money at A$0.030) | FY2026 AR |
Turnbull options | 10,000,000 / 10,000,000 / 10,000,000 | A$0.08 (Aug 2028) / A$0.12 (Aug 2029) / A$0.15 (Aug 2029) | FY2026 AR |
Performance rights (vested, unconverted) | 36,000,000 | Nil exercise price; expiry 4 Dec 2027 | FY2026 AR |
Fully diluted total | Approx. 787.7 million | — | Derived |
Analyst Conclusions
Management guidance
Management provides no financial guidance. Operational guidance from the FY2026 Annual Report (30 Sep 2026) is:
Titan West (Fortescue-operated): two-hole RC/diamond programme planned for late October or November 2026, subject to rig availability; track repairs required after rain damage; Titan West PEPR pending at the reporting date.
Parkinson Dam (Tasman 100%): up to 20 RC holes targeted for December 2026 or early 2027, subject to rig availability; all approvals now in place following PEPR approval (about 14 Oct 2026).
Funding: cash flow forecast indicates sufficient funds for at least 12 months including the Parkinson Dam programme; further funding beyond that period depends on results and capital raising.
Consensus growth expectations
None. No analyst coverage.
Bull case
-
Titan West discovery potential with zero cost to Tasman. The MT survey identified a deep conductor coincident with a dense gravity body in the Olympic Dam district, and the only historic hole (WMC, 1981) did not adequately test it. Fortescue bears the drilling cost; a significant intercept would re-rate Tasman's 49% interest without any capital contribution (FY2026 AR; ASX 27 Jul 2026).
-
Parkinson Dam offers 20 untested, fully permitted targets around a high-grade core. PD63 (21 m at 21 g/t Au, 83 g/t Ag) proves a high-grade system exists; the 2026 review identified a possible feeder intrusion at about 1,100 m depth. Twenty holes materially increase discovery odds versus a typical microcap programme (FY2026 AR).
-
Downside cushioned by cash and Eden. With A$5.65 million cash, no debt and an Eden stake worth A$12.3 million at 30 June 2026, the derived look-through EV at A$0.030 was approximately nil, implying the market was assigning little or no value to two drill-ready projects.
Bear case
-
Decades without a resource. Vulcan has been drilled since 2009, including about A$10 million of Rio Tinto-funded work and Fortescue's programmes, without a defined resource; Parkinson Dam has not been drilled since 2009. Base rates for greenfield drill success are low, and the board itself cautions that results may not lead to a resource (FY2026 AR).
-
Execution slippage and dilution. Drilling timelines have slipped by four to six months during 2026. Shares on issue almost doubled in FY2026 (279m to 554m), and 197.7m options plus 36m rights remain. Follow-up drilling after any success will require further raisings (FY2026 AR).
-
Eden is a volatile, loss-making prop. Eden lost A$6.78 million in FY2026 on A$1.98 million revenue and has repeatedly raised capital. Tasman's stake has been diluted from 33% to 12.6% in a year. A fall in Eden's share price would remove much of Tasman's asset backing (FY2026 AR Note 8).
Key catalysts and monitorables (next 12 months)
| Expected timing | Catalyst / monitorable | Why it matters |
|---|---|---|
| 30 Oct 2026 | September 2026 quarterly / Appendix 5B | Cash balance; confirmation of drilling dates |
| Late Oct to Nov 2026 | Titan West drilling commencement (Fortescue) and Titan West PEPR approval | First test of the MT/gravity target |
| Nov 2026 | AGM (date to be confirmed) | Governance votes; possible new incentive grants |
| Dec 2026 to early 2027 | Parkinson Dam drilling commencement | Largest Tasman-funded programme in over a decade |
| Q1 to Q2 CY2027 | Assay results from both programmes | Primary value catalyst |
| Ongoing | Fortescue's progress toward A$11 million earn-in (A$7.3 million spent to Mar 2026) | Determines whether Tasman dilutes to 20% or must contribute |
| Ongoing | Eden share price and any Eden value-return mechanism (sale or in-specie distribution) | Largest component of NAV |
| By 14 Jun 2028 | TASO option exercise (A$0.02) | Potential A$2.4 million cash inflow |
| Ongoing | New project acquisitions | Pipeline diversification |
Concluding analyst verdict
Tasman Resources has completed the most important corporate transformation in its 39-year history. A year ago it was a heavily indebted, going-concern-qualified holding company consolidating a loss-making US/Indian clean-technology business. Today, after Eden's deconsolidation, the repayment or conversion of Solomon-family loans, and two placements, it is a debt-free South Australian explorer with A$5.65 million cash, a 12.6% Eden stake worth about A$12.3 million at the end of June, and two drill programmes fully or nearly permitted. The FY2026 headline profit of A$16.5 million is an accounting artefact and should be ignored; the real story is balance-sheet repair.
The investment case now reduces to two binary drilling events over the next six to nine months. Titan West offers genuine Olympic Dam-district IOCG optionality at no cost to Tasman, while Parkinson Dam offers twenty untested targets around a proven high-grade gold-silver core. At the last verified price of A$0.030, the market appears to ascribe roughly nil value to these assets once cash and the Eden stake are netted off, which provides an asymmetric set-up if Eden's valuation holds.
The countervailing evidence is substantial. The company has explored Lake Torrens since 1998 and Parkinson Dam since 2006 without defining a resource; its best asset is controlled by a partner that can dilute it to 20%; its board lost its only geologist just as drilling begins; incentive hurdles were trivially low; and repeated timing slippage has already halved the share price from its June peak. Asset backing also depends on a volatile, loss-making associate.
On balance, Tasman is a high-risk, catalyst-driven speculation with unusually strong asset coverage for an explorer of its size. The key monitorables are drill commencement on schedule, Fortescue's continued funding, and Eden's share price. No rating or price target is given, consistent with the absence of verifiable forecasts.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure | Background / prior roles | Education | Source |
|---|---|---|---|---|---|
Gregory H. Solomon | Executive Chairman | Chairman and director since 1987 (39 years) | Solicitor with more than 30 years of Australian and international experience in mining law, commercial negotiation (including numerous mining and exploration JVs) and corporate law; partner of Solomon Brothers; public company directorships since 1984. Other listed directorships in past three years: Conico Ltd, Eden Innovations Ltd (Executive Chairman and interim CEO of Eden per FY2025 AR) | LLB | FY2026 AR; FY2025 AR |
Louis Varrasso | Non-Executive Director | Since 28 Nov 2025 | Director of Corporate Finance at PEAK Asset Management; four years at Asenna Wealth Solutions (trading and corporate advisory); operational experience in mineral recovery at Newmont. No other listed directorships in past three years. | — | FY2026 AR |
Adam Turnbull | Non-Executive Director | Since 24 May 2026 | Executive and company director with a career across construction, infrastructure, minerals, luxury goods and capital markets; private company board roles; Non-Executive Director of Forrestania Resources Ltd (ASX: FRS) since July 2025 | — | FY2026 AR |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Context | Source |
|---|---|---|---|
27 Nov 2024 | Brett Tucker appointed CFO/Company Secretary; Jamie Scoringe resigns | Administrative transition | FY2025 AR |
28 Nov 2025 | Louis Varrasso appointed NED; Guy Le Page (director since Feb 2001, the board's geologist and Competent Person) resigns | Coincided with Peak Asset Management lead-managing the A$2 million placement; introduces capital-markets expertise | FY2026 AR |
24 May 2026 | Adam Turnbull appointed NED; Douglas Solomon (director since April 2003) resigns | Announced alongside the A$4.05 million placement; Turnbull a placement participant (8.7m shares at appointment) | FY2026 AR; ASX 25 May 2026 |
Directors' Remuneration
| Person | Salary and fees | Superannuation | Performance rights (share-based) | Total | Notes |
|---|---|---|---|---|---|
G. Solomon (Exec Chair) | 207,500 | 24,900 | 252,000 | 484,400 | Includes Eden remuneration to 8 Sep 2025; Tasman fees settled A$87,500 cash plus 5,421,809 shares (A$62,500) |
D. Solomon (NED, resigned 24 May 2026) | 43,350 | 5,202 | 252,000 | 300,552 | Includes Eden remuneration to 8 Sep 2025 |
G. Le Page (NED, resigned 28 Nov 2025) | 15,000 | 1,800 | 0 | 16,800 | Settled in shares |
L. Varrasso (NED, from 28 Nov 2025) | 21,660 | 2,599 | 252,000 | 276,259 | — |
A. Turnbull (NED, from 24 May 2026) | 4,227 | 0 | 0 | 4,227 | Invoiced via TALM Investments Pty Ltd |
A. Larsen (Eden director, to 8 Sep 2025) | 46,383 | 0 | 0 | 46,383 | Eden Chief Scientist consultancy |
Total | 338,120 | 34,501 | 756,000 | 1,128,621 | — |
Directors' Remuneration (Annual)
| KMP total remuneration (AUD) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Group KMP total | 1,082,776 | 1,054,583 | 1,128,621 |
G. Solomon total | 505,000 | 501,750 | 484,400 |
Governance Overview
| Attribute | Status | Source |
|---|---|---|
Board size | Three | FY2026 AR |
Independence | Executive Chairman is not independent (executive, founder, major shareholder via Arkenstone, related-party legal and management services). Varrasso's independence is qualified by his employment at Peak Asset Management, which received A$120,000 in fees plus 40m lead manager options (A$584,000 fair value), of which 12m options were transferred to his entity K-Sum Capital. Turnbull is a substantial personal shareholder. | FY2026 AR related party note |
Chair/CEO separation | No CEO; chair is executive | FY2026 AR |
Committees | Remuneration committee referenced for NED fees; no separate audit committee disclosure retrieved. Board met formally three times in FY2026, with most matters handled by circular resolution. | FY2026 AR |
ASX Corporate Governance Principles | Appendix 4G lodged 30 Sep 2026; Recommendation 1.1 (board charter) not fully followed, with explanation in the Corporate Governance Statement; Recommendations 1.2 to 1.4 complied with | Kalkine, 30 Sep 2026 |
D&O insurance | Premium A$18,915 | FY2026 AR |
Related-party services | Princebrook Pty Ltd management fees A$12,273 (FY2025: A$194,819); Solomon Brothers legal fees A$18,770 | FY2026 AR Note 18 |
Major Shareholders
| Holder | Shares | % (at notice date) | Notice date | Comment | Source |
|---|---|---|---|---|---|
March Bells Pty Ltd (Douglas Solomon family trust) | 78,211,292 | 27.99 | — | % calculated on a much smaller share base; substantially diluted by 2025-2026 issues | InvestSMART substantial holder listing |
Arkenstone Pty Ltd (Gregory Solomon family trust) | 68,291,832 | 24.44 | — | As above | InvestSMART substantial holder listing |
7 Enterprises Pty Ltd (controller: Daniel Raihani) | 45,500,000 | Approx. 8.2 (derived on 553.99m) | 12 Jun 2026 (change on 9 Jun 2026) | Became substantial 14 Jan 2026; further notices 3 Feb, 13 Feb, 1 Jun and 12 Jun 2026 | Form 604, 12 Jun 2026 |
Directors' Shareholdings
| Director | Shares | Options | Performance rights | Approx. % of shares (derived) |
|---|---|---|---|---|
Gregory Solomon | 90,886,920 | 21,066,268 | 12,000,000 | 16.4 |
Adam Turnbull | 8,700,000 | 34,207,150 | 0 | 1.6 |
Louis Varrasso | 4,809,756 | 12,600,000 | 12,000,000 | 0.9 |
Competitive Landscape
Key Competitors
| # | Company | Ticker | Relevance to Tasman | Relative positioning | Source / verification |
|---|---|---|---|---|---|
| 1 | BHP Group | ASX: BHP | Owns and operates Olympic Dam (30 km south of EL 6416), Prominent Hill, Carrapateena and Oak Dam; the dominant Gawler Craton IOCG operator and natural acquirer of discoveries | Global major; incomparable scale | FY2025 AR (Olympic Dam, Oak Dam references) |
| 2 | Fortescue Ltd | ASX: FMG | Tasman's JV partner and manager at Lake Torrens; also a competitor for prospective ground | Global major; partner rather than rival on EL 6416 | FY2026 AR |
| 3 | Coda Minerals | ASX: COD | Stuart Shelf copper-cobalt (Elizabeth Creek / Emmie Bluff) near Olympic Dam | Resource-stage peer; more advanced | — |
| 4 | Investigator Resources | ASX: IVR | Paris silver project, Gawler Craton epithermal; the closest commodity/style analogue to Parkinson Dam | Resource-stage silver developer | — |
| 5 | Barton Gold | ASX: BGD | Gawler Craton gold (Tunkillia, Tarcoola); competes for SA gold exploration capital | Resource-stage | — |
| 6 | Cobra Resources | ASX: C6C | Gawler Craton gold and rare earths | Early resource stage | — |
| 7 | Marmota | ASX: MEU | Gawler Craton gold (Aurora Tank) | Exploration / early resource | — |
| 8 | Petratherm | ASX: PTR | Gawler Craton exploration (heavy minerals, gold) | Exploration | — |
| 9 | Miramar Resources | ASX: M2R | Aggregator-listed peer (TipRanks) | Exploration microcap | TipRanks peer list |
| 10 | Fin Resources | ASX: FIN | Aggregator-listed peer (TipRanks) | Exploration microcap | TipRanks peer list |
| 11 | Sabre Resources | ASX: SBR | Aggregator-listed peer (TipRanks, Motley Fool) | Exploration microcap | TipRanks; Motley Fool |
Peer Comparison FY2026
| Metric | Tasman (TAS) | Coda Minerals (COD) | Investigator Resources (IVR) | Barton Gold (BGD) |
|---|---|---|---|---|
Revenue (latest FY) | A$0.19 million (deconsolidated Eden stub) | — | — | — |
Revenue growth | n/m | — | — | — |
Margins | n/m (explorer) | n/m (explorer) | n/m (explorer) | n/m (explorer) |
R&D intensity | n/m | n/m | n/m | n/m |
Major partner carry | Yes (Fortescue, 49% to 20%) | — | — | — |
Listed investment backing | Yes (Eden stake, A$12.3 million at 30 June 2026) | No (to analyst's knowledge) | No (to analyst's knowledge) | No (to analyst's knowledge) |



